Fungal Infections of the Central Nervous System

2019 ◽  
Vol 39 (03) ◽  
pp. 343-357 ◽  
Author(s):  
Dan Tong Jia ◽  
Kiran Thakur

Fungal central nervous system infections present in a myriad of clinical manifestation and remain a significant diagnostic challenge. Presenting symptoms, cerebrospinal fluid analysis, conventional fungal serum markers and imaging correlates of disease are seldom sensitive or specific; fungal culture growth or histopathologic analysis are often required for definitive diagnoses but limited by feasibility. Novel diagnostic tools (such as the cryptococcal antigen and next-generation sequencing) have increased diagnostic potency when available but require further studies to define their utility.Invasive fungal infections are an emerging health threat in the setting of increased immunomodulatory treatments, advancements in transplant medicine and increased world-wide travel. Therefore, strong clinical suspicion from epidemiologic clues, clinical progression and presence of CNS dissemination risk factors must be exercised to pursue broad diagnostic workups and rapidly initiate medical and surgical management. This article will describe the epidemiology, clinical presentations, diagnostic approach and therapeutic interventions for fungal infections in the central nervous system.

2017 ◽  
Vol 6 (3) ◽  
pp. e123-e133 ◽  
Author(s):  
Matthew W McCarthy ◽  
Darius Kalasauskas ◽  
Vidmantas Petraitis ◽  
Ruta Petraitiene ◽  
Thomas J Walsh

Author(s):  
Haroldo C. de Oliveira ◽  
Rafael F. Castelli ◽  
Diogo Kuczera ◽  
Taiane N. Souza ◽  
Caroline M. Marcos ◽  
...  

2004 ◽  
Vol 39 (4) ◽  
pp. 505-518 ◽  
Author(s):  
Joseph Perdigao ◽  
Rafael Rojas ◽  
Laura Frascheri Verzelli ◽  
Mauricio Castillo

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Peiqing Chen ◽  
Wenjuan Zhao ◽  
Yanjie Guo ◽  
Juan Xu ◽  
Ming Yin

CX3C chemokine ligand 1 (CX3CL1) is an intriguing chemokine belonging to the CX3C family. CX3CL1 is secreted by neurons and plays an important role in modulating glial activation in the central nervous system after binding to its sole receptor CX3CR1 which mainly is expressed on microglia. Emerging data highlights the beneficial potential of CX3CL1-CX3CR1 in the pathogenesis of Alzheimer’s disease (AD), a common progressive neurodegenerative disease, and in the progression of which neuroinflammation plays a vital role. Even so, the importance of CX3CL1/CX3CR1 in AD is still controversial and needs further clarification. In this review, we make an attempt to present a concise map of CX3CL1-CX3CR1 associated with AD to find biomarkers for early diagnosis or therapeutic interventions.


Sign in / Sign up

Export Citation Format

Share Document